{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:34:44Z","timestamp":1784262884009,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF2011-02350693"],"award-info":[{"award-number":["RF2011-02350693"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41431-019-0350-4","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T16:05:50Z","timestamp":1550678750000},"page":"1113-1120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A novel dominant-negative FGFR1 variant causes Hartsfield syndrome by deregulating RAS\/ERK1\/2 pathway"],"prefix":"10.1038","volume":"27","author":[{"given":"Pietro","family":"Palumbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Petracca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2733-513X","authenticated-orcid":false,"given":"Roberto","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Nardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Carmine","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Di Schiavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Carella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-194X","authenticated-orcid":false,"given":"Lucia","family":"Micale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Castori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"key":"350_CR1","unstructured":"Dhamija R, Babovic-Vuksanovic D. Hartsfield syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132018 (last updated: 3 Mar 2016)."},{"key":"350_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/jmedgenet-2013-101603","volume":"50","author":"N Simonis","year":"2013","unstructured":"Simonis N, Migeotte I, Lambert N, Perazzolo C, De Silva DC, Dimitrov B, et al.\u00a0FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly. J Med Genet. 2013;50:585\u201392.","journal-title":"J Med Genet"},{"key":"350_CR3","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1093\/hmg\/ddw064","volume":"25","author":"S Hong","year":"2016","unstructured":"Hong S, Hu P, Marino J,\u00a0Hufnagel SB, Hopkin RJ, Toromanovi\u0107 A, et al. Dominant-negative kinase domain mutations in FGFR1 can explain the clinical severity of Hartsfield syndrome. Hum Mol Genet. 2016;25:1912\u201322.","journal-title":"Hum Mol Genet"},{"key":"350_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/wdev.176","volume":"4","author":"DM Ornitz","year":"2015","unstructured":"Ornitz DM &\u00a0Itoh N. The fibroblast growth factor signaling pathway. Wiley Interdisciplinary Rev Dev Biol. 2015;4:215\u201366.","journal-title":"Wiley Interdisciplinary Rev Dev Biol"},{"key":"350_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.gendis.2014.09.005","volume":"1","author":"CM Teven","year":"2014","unstructured":"Teven CM, Farina EM, Rivas J, Reid RR. Fibroblast growth factor (FGF) signaling in development and skeletal diseases. Genes Dis. 2014;1:199\u2013213.","journal-title":"Genes Dis"},{"key":"350_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ng1122","volume":"33","author":"C Dode","year":"2013","unstructured":"Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Souss-Yanicostas N,\u00a0et al. Loss- of- function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2013;33:463\u20135.","journal-title":"Nat Genet"},{"key":"350_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/gim.2014.166","volume":"17","author":"C Villanueva","year":"2015","unstructured":"Villanueva C, Jacobson-Dickman E, Xu C, Manouvrier S, Dwyer AA, Sykiotis GP,\u00a0et al. Congenital hypogonadism with split hand\/foot malformation: a clinical entity with high frequency of FGFR1 mutations. Med Genet. 2015;17:651\u20139.","journal-title":"Med Genet"},{"key":"350_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ejmg.2014.04.002","volume":"57","author":"J Tommiska","year":"2014","unstructured":"Tommiska J, K\u00e4ns\u00e4kaski J, Christiansen P, J\u00f8rgensen N, Lawaetz JG, Juul A. Genetics of congenital hypogonadotropic hypogonadism in Denmark. Eur J Med Genet. 2014;57:345\u20138.","journal-title":"Eur J Med Genet"},{"key":"350_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/cen.12504","volume":"82","author":"M Hero","year":"2015","unstructured":"Hero M, Laitinen EM, Varimo T, Vaaralahti K, Tommiska J, Ravio T.\u00a0Childhood growth of females with Kallmann syndrome and FGFR1 mutations. Clin Endocrinol (Oxf). 2015;82:122\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"350_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng1194-269","volume":"8","author":"M Muenke","year":"1994","unstructured":"Muenke M, Schell U, Hehr A, Robin N, Losken HA, Schinzel P,\u00a0et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet. 1994;8:269\u201374.","journal-title":"Nat Genet"},{"key":"350_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1086\/427956","volume":"76","author":"KE White","year":"2005","unstructured":"White KE, Cabral JM, Davis SI, Fishburn T, Evans WE, Ichikawa S,\u00a0et al. Mutations that cause osteoglophonic dysplasia define novel roles for fgfr1 in bone elongation. Am J Human Genet. 2005;76:361\u20137.","journal-title":"Am J Human Genet"},{"key":"350_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ajhg.2016.02.006","volume":"98","author":"JT Bennett","year":"2016","unstructured":"Bennett JT, Tan TY, Alcantara D, Tetrault M, Timms AE, Jensen D,\u00a0et al. Mosaic activating mutations in fgfr1 cause encephalocraniocutaneous lipomatosis. Am J Human Genet. 2016;98:579\u201387.","journal-title":"Am J Human Genet"},{"key":"350_CR13","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIRCRESAHA.111.255950","volume":"110","author":"N Brady","year":"2013","unstructured":"Brady N, Chuntova P, Bade LK, Schwertfeger KL. The FGF\/FGFR axis as a therapeutic target in breast cancer. Expert Rev Endocrinol Metab. 2013;110:e29\u201339.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"350_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2017.04.017","volume":"621","author":"H Luo","year":"2017","unstructured":"Luo H, Zheng R, Zhao Y, Wu J, Li J, Jiang F,\u00a0et al. A dominant negative FGFR1 mutation identified in a Kallmann syndrome patient. Gene. 2017;621:1\u20134.","journal-title":"Gene"},{"key":"350_CR15","doi-asserted-by":"publisher","first-page":"15933","DOI":"10.1074\/jbc.M909299199","volume":"275","author":"ME Lopez","year":"2000","unstructured":"Lopez ME\u00a0&\u00a0Korc M. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2. J Biol Chem. 2000;275:15933\u20139.","journal-title":"J Biol Chem"},{"key":"350_CR16","first-page":"365","volume":"132","author":"S Rozen","year":"2000","unstructured":"Rozen S &\u00a0Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000;132:365\u201386.","journal-title":"Methods Mol Biol"},{"key":"350_CR17","doi-asserted-by":"publisher","first-page":"e46642","DOI":"10.1371\/journal.pone.0046642","volume":"7","author":"L Micale","year":"2012","unstructured":"Micale L, Loviglio MN, Manzoni M, Fusco C, Augello B, Migliavacca E,\u00a0et al. A fish-specific transposable element shapes the repertoire of p53 target genes in zebrafish. PLoS ONE. 2012;7:e46642.","journal-title":"PLoS ONE"},{"key":"350_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13046-017-0534-0","volume":"36","author":"H Yuan","year":"2017","unstructured":"Yuan H, Li ZM, Shao J, Ji WX, Xia W, Lu S. FGF2\/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells. J Exp Clin Cancer Res. 2017;36:72.","journal-title":"J Exp Clin Cancer Res"},{"key":"350_CR19","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1038\/onc.2015.344","volume":"35","author":"D Weekes","year":"2016","unstructured":"Weekes D, Kashima TG, Zandueta C, Perurena N, Thomas DP, Sunters A, et al. Regulation of osteosarcoma cell lung metastasis by the c-Fos\/AP-1 target FGFR1. Oncogene. 2016;35:2852\u201361.","journal-title":"Oncogene"},{"key":"350_CR20","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/ajmg.a.36621","volume":"164A","author":"R Dhamija","year":"2014","unstructured":"Dhamija R, Kirmani S, Wang X, Ferber MJ, Wieben ED, Lazaridis KN,\u00a0et al. Novel de novo heterozygous FGFR1 mutation in two siblings with Hartsfield syndrome: a case of gonadal mosaicism. Am J Human Genet. 2014;164A:2356\u20139.","journal-title":"Am J Human Genet"},{"key":"350_CR21","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/ajmg.a.37731","volume":"170","author":"R Prasad","year":"2016","unstructured":"Prasad R, Brewer C, Burren CP. Hartsfield syndrome associated with a novel heterozygous missense mutation in FGFR1 and incorporating tumoral calcinosis. Am J Human Genet. 2016;170:2222\u20135.","journal-title":"Am J Human Genet"},{"key":"350_CR22","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1002\/ajmg.a.37869","volume":"170","author":"Y Shi","year":"2016","unstructured":"Shi Y, Dhamija R, Wren C, Wang X, Babovic-Vuksanovic D, Spector E. Detection of gonadal mosaicism in Hartsfield syndrome by next generation sequencing. Am J Human Genet. 2016;170:3359.","journal-title":"Am J Human Genet"},{"key":"350_CR23","doi-asserted-by":"publisher","first-page":"16034","DOI":"10.1038\/hgv.2016.34","volume":"3","author":"M Takagi","year":"2016","unstructured":"Takagi M, Miyoshi T, Nagashima Y, Shibata N, Yagi H, Fukuzawa R, et al. Novel heterozygous mutation in the extracellular domain of FGFR1 associated with Hartsfield syndrome. Hum Genome Var. 2016;3:16034.","journal-title":"Hum Genome Var"},{"key":"350_CR24","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1177\/0022034517726496","volume":"96","author":"LA Lansdon","year":"2017","unstructured":"Lansdon LA, Bernabe HV, Nidey N, Standley J, Schnieders MJ, Murray JC. The use of variant maps to explore domain-specific mutations of FGFR1. J Dent Res. 2017;96:1339\u201345.","journal-title":"J Dent Res"},{"key":"350_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijporl.2017.04.035","volume":"98","author":"JD Oliver","year":"2017","unstructured":"Oliver JD, Menapace DC, Cofer SA. Otorhinolaryngologic manifestations of Hartsfield syndrome: case series and review of literature. Int J Pediatr Otorhinolaryngol. 2017;98:4\u20138.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"350_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-cellbio-092910-154005","volume":"27","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol. 2011;27:107\u201332.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"350_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1056\/NEJMra1205406","volume":"368","author":"AM Choi","year":"2013","unstructured":"Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med. 2013;368:651\u201362.","journal-title":"N Engl J Med"},{"key":"350_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nature16063","volume":"528","author":"L Cinque","year":"2015","unstructured":"Cinque L, Forrester A, Bartolomeo R, Svelto M, Venditti R, Montefusco S,\u00a0et al. FGF signalling regulates bone growth through autophagy. Nature. 2015;528:272\u20135.","journal-title":"Nature"},{"key":"350_CR29","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.1074\/jbc.RA118.002293","volume":"293","author":"Z Wang","year":"2018","unstructured":"Wang Z, Huang J, Zhou S, Luo F, Tan Q, Sun X,\u00a0et al. Loss of Fgfr1 in chondrocytes inhibits osteoarthritis by promoting autophagic activity in temporomandibular joint. J Biol Chem. 2018;293:8761\u201374.","journal-title":"J Biol Chem"},{"key":"350_CR30","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIRCRESAHA.111.255950","volume":"110","author":"J Zhang","year":"2012","unstructured":"Zhang J, Liu J, Huang Y, Chang JY, Liu L, McKeehan WL,\u00a0et al. FRS2alpha-mediated FGF signals suppress premature differentiation of cardiac stem cells through regulating autophagy activity. Circ Res. 2012;110:e29\u2013e39.","journal-title":"Circ Res"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0350-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0350-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0350-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:59:13Z","timestamp":1684616353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-019-0350-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["350"],"URL":"https:\/\/doi.org\/10.1038\/s41431-019-0350-4","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,20]]},"assertion":[{"value":"28 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}